A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)

NCT04880850 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

582

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin icodec
DRUG: Insulin glargine
DRUG: Insulin aspart

Sponsor

Novo Nordisk A/S